Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that it enclosed the transcript of the Investor Conference Call for Q4FY24 held on Thursday, May 16, 2024 at 12:00 Noon (IST). The transcript is also available on the website of the Company at https://www.mankindpharma.com/media/investor/q4-fy24-earning-concall-transcript_final1716361558.pdf.
The above information is a part of company’s filings submitted to BSE.